title: Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors.
abstract: BACKGROUND
  Mast cells (MC) are multifunctional effector cells of the immune system. They derive from uncommitted CD34(+) hemopoietic progenitor cells (HPC). Depending on the stage of maturation and the environment, MC variably express differentiation- and activation-linked antigens. Little is known, however, about the regulation of expression of such antigens in immature human MC.
  
  
  METHODS
  We analyzed expression of CD antigens on human MC grown from cord blood-derived CD34(+) HPC. The HPC were isolated by magnetic cell sorting (MACS) and FACS to >97% purity, and were cultured in stem cell factor (SCF) and interleukin (IL)-6 with or without additional cytokines (IL-4 or IL-10) in serum-free medium. The cell surface phenotype of MC was determined by monoclonal antibodies and flow cytometry.
  
  
  RESULTS
  Cultured MC progenitors were found to react with antibodies against various CD antigens including CD58, CD63, CD117, CD147, CD151, CD203c, and CD172a, independent of the growth factors used and time-point investigated (days 14-42). CD116 [granulocyte-macrophage colony-stimulating factor receptor alpha (GM-CSFRalpha)] and CD123 (IL-3Ralpha) were expressed on MC precursors on day 14, but disappeared thereafter. Cultured MC did not express CD2, CD3, CD5, CD10, CD19, or CD25. Addition of IL-10 to MC cultures showed no effect on expression of CD antigens. However, IL-4 was found to promote expression of CD35 and CD88 on cultured MC without changing expression of other CD antigens.
  
  
  CONCLUSIONS
  Most MC antigens may already be expressed at an early stage of mastopoiesis. Whereas IL-3R and GM-CSFRs are lost during differentiation of MC, these cells may acquire complement receptors (CD35, CD88) under the influence of distinct cytokines.
authors.affiliation: Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
authors.forename: G-H
authors.initials: GH
authors.lastname: Schernthaner
authors.forename: A W
authors.initials: AW
authors.lastname: Hauswirth
authors.forename: M
authors.initials: M
authors.lastname: Baghestanian
authors.forename: H
authors.initials: H
authors.lastname: Agis
authors.forename: M
authors.initials: M
authors.lastname: Ghannadan
authors.forename: C
authors.initials: C
authors.lastname: Worda
authors.forename: M-T
authors.initials: MT
authors.lastname: Krauth
authors.forename: D
authors.initials: D
authors.lastname: Printz
authors.forename: G
authors.initials: G
authors.lastname: Fritsch
authors.forename: W R
authors.initials: WR
authors.lastname: Sperr
authors.forename: P
authors.initials: P
authors.lastname: Valent
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000378:metabolism*; D002454:Cell Differentiation; D002478:Cells, Cultured; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D015847:Interleukin-4 / Q000378:metabolism; D008407:Mast Cells / Q000166:cytology* / Q000276:immunology / Q000378:metabolism; D051379:Mice; D010641:Phenotype; D044087:Receptor, Anaphylatoxin C5a / Q000378:metabolism; D017463:Receptors, Complement 3b / Q000378:metabolism
chemical_list: D015703:Antigens, CD; D044087:Receptor, Anaphylatoxin C5a; D017463:Receptors, Complement 3b; D015847:Interleukin-4